chitosan has been researched along with Nasal Catarrh in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brar, T; Brown, A; Lal, D; Marino, MJ; Miglani, A | 1 |
| Huang, TW; Li, ST; Young, TH | 1 |
| Das, S; Medina, JG | 1 |
| Kim, CK; Kim, ST | 1 |
1 trial(s) available for chitosan and Nasal Catarrh
| Article | Year |
|---|---|
Sprayable chitosan/starch-based sealant reduces adhesion formation in a sheep model for chronic sinusitis.
Topics: Animals; Chitosan; Chronic Disease; Disease Models, Animal; Endoscopy; Paranasal Sinuses; Postoperative Complications; Prospective Studies; Rhinitis; Sheep; Sinusitis; Starch; Tissue Adhesions | 2013 |
3 other study(ies) available for chitosan and Nasal Catarrh
| Article | Year |
|---|---|
Outcomes of Frontal Sinus Stenting With Steroid Impregnated Microsponge Versus Steroid-Eluting Implant.
Topics: Chitosan; Chronic Disease; Endoscopy; Frontal Sinus; Humans; Rhinitis; Sinusitis; Stents; Steroids; Treatment Outcome; Triamcinolone | 2023 |
Chitosan-hyaluronan: promotion of mucociliary differentiation of respiratory epithelial cells and development of olfactory receptor neurons.
Topics: Cell Differentiation; Cells, Cultured; Chitosan; Chronic Disease; Humans; Hyaluronic Acid; Nasal Mucosa; Olfactory Receptor Neurons; Rhinitis; Signal Transduction | 2019 |
Water-soluble chitosan-based antisense oligodeoxynucleotide of interleukin-5 for treatment of allergic rhinitis.
Topics: Animals; Cations; Chitosan; Female; Genetic Therapy; Humans; Hypersensitivity; Interleukin-5; Mice; Mice, Inbred BALB C; Oligonucleotides, Antisense; Rhinitis; Solubility; Th2 Cells; Water | 2007 |